Study sample collection for sepsis and after cardiac arrest
Part of Heart & circulation, Infections clinical trials.
This trial collects and stores small samples from people in the ICU who are either being treated for sepsis or who have survived a non-traumatic cardiac arrest. It may help researchers better understand how the body changes after severe infection or after revival, which could improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 16 or older
- Be admitted to the ICU (intensive care unit)
- Be diagnosed with sepsis, or be in the post-resuscitation period after surviving a non-traumatic cardiac arrest
- Have a confirmed or strongly suspected infection for sepsis (often alongside specific body-response signs)
- Be willing to participate
- Not have a DNAR order (do-not-attempt-resuscitation)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
This trial is a registry, which means the researchers collect information about people who were treated in an intensive care unit after a cardiac arrest. It may help improve understanding of outcomes and care, which can guide future treatment.
This study looks at how cardiac arrest affects people's quality of life and survival after being in the intensive care unit. Participating may help doctors understand how to improve care for future patients.
This trial looks at how the body’s inflammation response behaves after someone has a cardiac arrest and was treated in the ICU. It may help doctors understand which patients could benefit from treatments that target harmful inflammation after resuscitation.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
Hear when a new Cardiac Arrest trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.